Cargando…

Stafia‐1: a STAT5a‐Selective Inhibitor Developed via Docking‐Based Screening of in Silico O‐Phosphorylated Fragments

We present a new approach for the identification of inhibitors of phosphorylation‐dependent protein–protein interaction domains, in which phenolic fragments are adapted by in silico O‐phosphorylation before docking‐based screening. From a database of 10 369 180 compounds, we identified 85 021 natura...

Descripción completa

Detalles Bibliográficos
Autores principales:	Natarajan, Kalaiselvi, Müller‐Klieser, Daniel, Rubner, Stefan, Berg, Thorsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973011/ https://www.ncbi.nlm.nih.gov/pubmed/31503360 http://dx.doi.org/10.1002/chem.201904147

Ejemplares similares

Rational development of Stafib-2: a selective, nanomolar inhibitor of the transcription factor STAT5b
por: Elumalai, Nagarajan, et al.
Publicado: (2017)

Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a**
por: Elumalai, Nagarajan, et al.
Publicado: (2015)

Asymmetrically Substituted m‐Terphenyl Phosphates Inhibit the Transcription Factor STAT5a
por: Müller‐Klieser, Daniel, et al.
Publicado: (2021)

Docking, virtual high throughput screening and in silico fragment-based drug design
por: Zoete, Vincent, et al.
Publicado: (2009)

Development of Erasin: a chromone-based STAT3 inhibitor which induces apoptosis in Erlotinib-resistant lung cancer cells
por: Lis, Christian, et al.
Publicado: (2017)

Identification of STAT1 and STAT3 Specific Inhibitors Using Comparative Virtual Screening and Docking Validation
por: Szelag, Malgorzata, et al.
Publicado: (2015)

Screening for serine/threonine kinases phosphorylating Stat5
por: Berger, Angelika, et al.
Publicado: (2011)

An NMR-Guided Screening Method for Selective Fragment Docking and Synthesis of a Warhead Inhibitor
por: Khattri, Ram B., et al.
Publicado: (2016)

GM-CSF-activated STAT5A regulates macrophage functions and inflammation in atherosclerosis
por: Nagenborg, Jan, et al.
Publicado: (2023)

In silico screening of mutational effects on enzyme-proteic inhibitor affinity: a docking-based approach
por: Dell'Orco, Daniele, et al.
Publicado: (2007)

Molecular docking based screening of Listeriolysin-O for improved inhibitors
por: Ghafari, Sara, et al.
Publicado: (2017)

In silico identification of potential SARS COV-2 2′-O-methyltransferase inhibitor: fragment-based screening approach and MM-PBSA calculations
por: El Hassab, Mahmoud A., et al.
Publicado: (2021)

Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies
por: John, Shalini, et al.
Publicado: (2011)

O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies
por: Freund, P, et al.
Publicado: (2017)

STAT2 phosphorylation and signaling
por: Steen, Håkan C, et al.
Publicado: (2013)

In silico fragmentation for computer assisted identification of metabolite mass spectra
por: Wolf, Sebastian, et al.
Publicado: (2010)

Identification of Inhibitors against Metastasis Protein “Survivin:” In silico Discovery Using Virtual Screening and Molecular Docking Studies
por: Mishra, Swechha, et al.
Publicado: (2017)

In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation
por: Hossain, Rajib, et al.
Publicado: (2021)

EGFR-mediated tumor immunoescape: The imbalance between phosphorylated STAT1 and phosphorylated STAT3
por: Concha-Benavente, Fernando, et al.
Publicado: (2013)

In Silico Optimization of Mass Spectrometry Fragmentation Strategies in Metabolomics
por: Wandy, Joe, et al.
Publicado: (2019)

Fragment docking supported by NMR shift perturbations
por: Brink, Tim ten, et al.
Publicado: (2014)

Binding mode information improves fragment docking
por: Jacquemard, Célien, et al.
Publicado: (2019)

In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008)

Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation
por: Niu, Guo-Juan, et al.
Publicado: (2018)

In Silico Exploration of Novel Tubulin Inhibitors: A Combination of Docking and Molecular Dynamics Simulations, Pharmacophore Modeling, and Virtual Screening
por: Hadizadeh, Farzin, et al.
Publicado: (2022)

Combining fragment docking with graph theory to improve ligand docking for homology model structures
por: Sarfaraz, Sara, et al.
Publicado: (2020)

Improving Blind Docking in DOCK6 through an Automated Preliminary Fragment Probing Strategy
por: Jofily, Paula, et al.
Publicado: (2021)

In –silico molecular docking analysis of prodigiosin and cycloprodigiosin as COX-2 inhibitors
por: Krishna, Pabba Shiva, et al.
Publicado: (2013)

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
por: Pu, Yinglan, et al.
Publicado: (2017)

Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies
por: Alzain, Abdulrahim A., et al.
Publicado: (2022)

The Selectivity of Fosfosal for STAT5b over STAT5a is Mediated by Arg566 in the Linker Domain
por: Gräb, Julian, et al.
Publicado: (2020)

Limits of Ligand Selectivity from Docking to Models: In Silico Screening for A(1) Adenosine Receptor Antagonists
por: Kolb, Peter, et al.
Publicado: (2012)

Stafiba: A STAT5‐Selective Small‐Molecule Inhibitor
por: Eckhardt, Katrin S., et al.
Publicado: (2022)

Towards Unraveling the Histone Code by Fragment Blind Docking
por: Bálint, Mónika, et al.
Publicado: (2019)

Pharmacophore modeling, in silico screening, molecular docking and molecular dynamics approaches for potential alpha-delta bungarotoxin-4 inhibitors discovery
por: Kumar, R. Barani, et al.
Publicado: (2015)

New Thiazole Carboxamide Derivatives as COX Inhibitors: Design, Synthesis, Anticancer Screening, In Silico Molecular Docking, and ADME Profile Studies
por: Hawash, Mohammed, et al.
Publicado: (2023)

An in silico method to assess antibody fragment polyreactivity
por: Harvey, Edward P., et al.
Publicado: (2022)

In Silico Docking of HNF-1a Receptor Ligands
por: Sridhar, Gumpeny Ramachandra, et al.
Publicado: (2012)

Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational Docking
por: Schuller, Marion, et al.
Publicado: (2020)

Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking
por: Schuller, Marion, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1395jh4jvdgke5tpnjisqqg1qv